相关实验视频
Updated: Jul 6, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
血清费里水平可以预测代谢功能障碍相关的脂肪性肝病患者的长期结果
Angelo Armandi1,2, Tiziana Sanavia3, Ramy Younes4
1Division of Gastroenterology and Hepatology, Department of Medical Sciences, University of Turin, Turin, Italy angelo.armandi@unito.it.
高血清费里水平预测代谢功能障碍相关的脂肪性肝病 (MASLD) 患者的长期结果会更差. 升高的费里表明MASLD患者肝脏相关事件和整体死亡率的风险显著增加.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 生物标志物 生物标志物
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题.
- 超血与MASLD中的肝纤维化严重程度有关,但其长期预后价值尚不清楚.
研究的目的:
- 评估血清费里丁对MASLD患者长期结果和死亡率的预测作用.
- 评估将血清费里丁纳入现有风险预测模型的影响.
主要方法:
- 一项针对1342名MASLD患者的多中心队列研究,随访时间中位数为96个月.
- 生存模型分析了基线血清费里和纵向事件之间的关系.
- 使用哈雷尔的C指数评估性能,并使用或不使用费里丁作为共同变量.
主要成果:
- 超血与50%的肝脏相关事件风险增加和27%的全因死亡风险增加相关.
- 确定了特定的费里丁值 (215.5微克/升用于肝脏事件,272微克/升用于整体死亡率).
- 包括费里改善了长期结果的纤维化-4和NAFLD纤维化得分的预测准确性.
结论:
- 血清费里丁是预测MASLD患者长期预后的有价值的生物标志物.
- 高水平的费里表明肝脏和整体健康不良结果的风险更高.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
相关概念视频
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...